The purpose of this CodeX Use Case Project Dashboard is to provide status updates for the most significant, overarching tasks associated with each Use Case. This dashboard will act to facilitate discussions regarding Use Case progress and performance for key tasks. CodeX Use Cases projects are in one of 3 stages:

  • CodeX Use Cases projects are in one of 3 stages, transitioned according to the Use Case Development Guidelines:

    • Use Cases are in the Discovery are ideas in the Backlog that have been proposed for future consideration, with a small group discussing, and aligning on a concept.
    • Use Cases in Active Community Planning are, as the name implies, being planned with Members - Identifying necessary stakeholders, objectives, deliverables, measures of success and schedules for fast-moving phases.
    • Use Case Projects in Active Community Execution are projects where models, mCODE-based FHIR IGs, implementations and pilots are currently under development, led by CodeX members.

Contact CodeX Program Management to learn more about any of the Use Cases below. Pre-Discovery and Archived Use Case Concepts can be found here. All are welcome to join the CodeX/mCODE Community of Practice to hear presentations on implementation work inside and outside of CodeX.

Use Cases and Objectives

Key Work Underway

Key Accomplishments

Active Community Execution

Cancer Registry Reporting

Enable reporting of mCODE-based cancer data from health center EHRs to a state and a private registry that are aggregating data for different reasons, substantially reducing duplication and burden while increasing reporting speed and accuracy.

COMPLETE Phase 0 - Collect requirements and build technical architecture needed for pilot activity - conveying essential patient data to registries in a timely/low burden way

COMPLETE Phase 0 - Health system(s) commitment for implementation, pilot activity completed

ON TRACK Begin phase 1 activities as outlined in the Cancer Registry Reporting section.

COMPLETE Phase 0 - Determine patient data to use

COMPLETE Phase 0 - Determine state registry endpoint for pilot

COMPLETE Phase 0 - Determine private registry endpoint for pilot

COMPLETE Phase 0 - Implement MedMorph reference architecture at a Health system and create plan definitions for a state and a private registry.

COMPLETE Phase 0 - Complete the data exchange between the health system and the state registry and the private registry, proving the underlying architecture. 

CANCELED Drafting PSS in FHIR IG Publishing Process - decided to publish under MedMorph as Content IG, separate PSS as needed

EHR Endpoints for Cancer Clinical Trials (ICAREdata)

Collect research-quality mCODE-based data in and share from EHRs to increase the value of real-world data for clinical trials, and reduce and potentially eliminate manual and/or duplicate data entry into case report forms. 

ON TRACK ICAREdata Phase 2 - 11 clinical trials participating in ICAREdata (5 activated embedded trials and 6 under the companion protocol). 10 health systems with contracts. 7 health systems currently sharing data to the ICAREdata infrastructure.

ON TRACK ICAREdata Adverse Event Reporting - Drafted initial AE model in draft CTCAE IG and documented AE clinical workflow. Developed IT implementation tracker. Extended period period into 2023. 2 health systems currently sharing adverse events data to the ICAREdata infrastructure. Aligning use case with Vulcan CR AE IG


COMPLETE Phase 1 – Demonstrated successful collection of Cancer Disease Status as a structured phrase in patient clinical note

COMPLETE Phase 2– An operational infrastructure with mCODE data flowing from health systems to the ICAREdata infrastructure

GenomeX - FHIR Genomics Data Exchange

IN PROGRESS Phase 0 Pilot implementation that will enable an end user, such as Children's Hospital of Los Angeles, to request a FHIR based genomics report from a testing lab, such as Tempus, using a restful FHIR API, receive and verify FHIR transmission and import it into the Epic Genomics Module.

ON TRACK Determine data elements to provide critical information included in genetic testing reports. Effort supported by the Payload sub-work group.

ON TRACK Determine data transmission mechanism to carry the FHIR data elements for genetic testing reports. Effort supported by the Payload sub-work group.

COMPLETE Use case goals, value and scope defined; Champions identified and Leadership team established meeting regularly

COMPLETE Planned for Phase 0 Pilot and Identification of focus areas for future Phases

COMPLETE Transitioned from Planning by the end of January and Execution Q1 2023

COMPLETE Established sub-work groups, Payload to determine data elements for genetic reports and Transport to determine data transmission mechanism for the next phases of work.

Integrated Trial Matching for Cancer Patients and Providers 

Leverage mCODE-based data standards and open APIs that enable interoperable, scalable, and accessible clinical trial matching services to improve the ability for patients to find clinical trials for which they may be eligible. 

DEFERRED Phase 2A – integration with PDMs and production clinical trial matching services, working with patient advocacy organizations to recruit patients to join application and test capability, expand to multiple cancer types and evaluate clinical trial matching service coverage

ON TRACK Phase 2B – expand data analysis to include additional patients and cancer types, integrate clinical trial matching at the point of care for prospective pilot 


COMPLETE Phase 0 Pilot using synthetic data to find trials via one matching services (Report)

COMPLETE Trial Matching PSS approved by HL7 BR&R Workgroup and TSC

COMPLETE Phase 1A – integration with Cancer Insights, recruiting patients to join application and test capability, evaluating the optimized patient data elements

COMPLETE Phase 1B – use of retrospective patient data from UTSW and Massive Bio, evaluating the optimized patient data elements 

mCODE++ Extraction

Software to enable existing EHRs and other systems to share cancer patient data conformant to the mCODE FHIR IG, to support a variety of use cases.

ON TRACK Implementing Extraction framework to support the ICAREdata project within the EHR Endpoints for Cancer Clinical Trials use case. 

Prior Authorization in Oncology

Facilitate sharing of mCODE-based clinical data between providers and payers to reduce burden and speed authorization or requests for more information.

ON TRACK Phase 1 - Use case is in the Execution Phase 

Members (eviCore/Evernorth, Varian, Mettle Solutions, ASTRO, MCG, ONS, Telligen, McKesson/Ontada) have confirmed prostate radiation oncology pilot. 

McKesson has identified clinical level practice management/workflow SMEs to engage in workflow evaluation, technical requirements and data.  They are focusing on synthetic data and test system for with a prime focus on prostate at this time

Bi-weekly technical team are progressing.  Workflow has been completed.  Identification of Data elements (demo graphics and clinical) has been completed (see below). 

COMPLETE Phase 1 - Test site system preparation by EHR/Varian and McKesson pilot sites

COMPLETE FHIR server set up by Varian and CRD, DTR programming by eviCore

IN PROGRESS Phase CRD, DTR and PAS IGs implementation

IN PROGRESS Pilot Outcomes/Whitepaper 

COMPLETE Phase 1 - Identification and documentation creation Scenarios to be tested


Documentation found here - PA in Oncology - Documents

COMPLETE Develop an end-to-end proof of concept with full prior authorization in conformance with Da Vinci standards

COMPLETE  The proof of concept features the Da Vinci prior authorization information exchange with two synthetic cancer patients who have mCODE elements.  The exchange shows extraction of mCODE from the EHR via a SMART-on-FHIR application.  This data pre-populate the FHIR questionnaires used in interaction between provider and payer.

COMPLETE  Breast and Prostate use cases and champions identified.  Request to move to planning phase completed.  Phases of Planning and key efforts to accomplish have been identified and vetted with members and the public.  

COMPLETE Identification of test site piloter

COMPLETE New demonstration from implementer/developer, MCG, was completed 5.11.22.  See PA in Oncology - Documents for demo video

COMPLETE Evaluation of patient demographic and clinical data elements to be used in use case and gap analysis to mCode.  Initial evaluation has been done but with a deeper dive into the workflow to identify the need for PA, the data needed at each step, may alter the data elements needed or not needed.

COMPLETE Phase 0 Pilot metrics identified by members

Radiation Therapy Treatment Data for Cancer

Leverage mCODE and extensions to enable sharing of critical radiation therapy treatment data for care coordination or data reuse (research, quality measurement, payer-required reporting).

ON TRACK RTTD project team is currently scoping new work 

ON TRACK RTTD Terminology team is updating the RT IG for version 2 release

ON TRACK Preparing for formal January 2024 IHE-RO Connectathon (RaySearch, Varian, Elekta, Epic)

ON TRACK Varian & RaySearch are designing initial pilot with interested health site(s) – Michigan, VA

COMPLETE CodeX Radiation Therapy Implementation Guide (STU 1):

COMPLETE Phase 3 complete - Epic, Varian, and RaySearch implemented the radiotherapy profiles in the XRTS framework at the January 2023 XRTS Workshop

COMPLETE RayCare 6A supports the mCODE Radiotherapy Course Summary and Radiotherapy Volume (2022)

Active Community Planning

CardX - Hypertension Management


Awaiting approval of HL7 Project Scope Statement. HL7 Project Proposal submitted and approved by Clinical Interoperability Council (CIC) with agreement to act as sponsoring work group, and co-sponsorship from the  Mobile Health Work Group.

Engaging interested community stakeholders, growing the member community, and identifying roles for members (i.e. potential pilot site, personal health intermediary, etc.)

Solidifying phased plan for testing, validation, and proof of concept

COMPLETE Use case identified by community Leadership and scope defined

COMPLETE Champions identified and Leadership team established meeting regularly

GenomeX - FHIR Genomics Operations


Developing mockups of the molecular tumor board application that will leverage the Genomics Reporting IG Operations with Beth Israel Deaconess Medical Center, the primary participant in the initial phase of the use case

Engaging interested community stakeholders, growing the member community, and identifying additional participants in the ongoing pilot efforts

COMPLETE Use case goals, value and scope defined; Champions identified and meeting regularly

COMPLETE Transitioned from Discovery to Planning stage by the end of February 2023

COMPLETE Engaged interested community members and prepared for an initial pilot phase focused on the Genomic Reporting IG Operations in support of molecular tumor review boards

Risk Evaluation and Mitigation Strategies

Create integrated, automated, efficient, and effective REMS programs by leveraging open data standards and creating the data infrastructure to enable REMS integration into the current workflow and data sharing across REMS stakeholders reducing undue burden 


Leadership meets weekly. Forming membership for the technical subgroup that will plan and execute on the pilot.  

Public meetings are scheduled for January, February, March and April 2023. Registration details follow: 

  • 2/14/23 at 1:00 PM ET Register here
  • 3/8/23 at 12:00 PM ET Register here
  • 4/11/23 at 1:pp PM ET Register here

The REMS use case team are presenting an update on their work at the February CodeX Community of Practice on 2/24/23 at 12:00 PM ET. Register here. 

Quality Measures for Cancer

Create a solution that demonstrates the ability to author and evaluate digital quality measures using the FHIR data model and mCODE, where applicable, for value-based programs and clinical quality improvement in the oncology domain

ON TRACK Expand portfolio of VA quality measures and repeat measure mapping, authoring, test bundle creation and testing steps

  • ASTRO measure: Oncology: Treatment Summary Communication - Radiation Oncology
    1. This is the ASTRO eCQM treatment summary measure – linked here
  • VA measure: Performance Status
    1. This is one of the VA measures - linked here

COMPLETE Phase 0 successfully completed


On Hold

Oncology Clinical Pathways 

Enable clinicians to use an oncology clinical pathway applications that accurately navigates to recommended treatments using mCODE-based data from the EHR.

  • No labels